DHX32: A Potential Drug Target and Biomarker for Pre-mRNA Splicing

Target Name: DHX32

NCBI ID: G55760

DHX32: A Potential Drug Target and Biomarker for Pre-mRNA Splicing

The pre-mRNA splicing process is a critical step in the regulation of gene expression in eukaryotic cells. It involves the removal of non-coding introns from the pre-mRNA and the addition of exons from aDNA template to create a functional RNA molecule that can be translated into protein. The protein responsible for this process is DHX32, which is a member of the X-linked RNA helicase family. In this article, we will explore DHX32 as a potential drug target and biomarker for pre-mRNA splicing disorders.

DHX32: Structure and Function

DHX32 is a 21 kDa protein that is expressed in most tissues of the body. It is a member of the X-linked RNA helicase family, which includes several proteins that are involved in the regulation of gene expression in females. DHX32 is localized to the nucleus and is predominantly composed of a single polypeptide chain.

DHX32 functions as a pre-mRNA splicing factor by promoting the loading of the pre-mRNA onto the splicing machinery. It does this by interacting with the protein CoRAS2, which is also a pre-mRNA splicing factor. CoRAS2 is a GTPase that is involved in the regulation of gene expression, and it functions as a negative regulator of DHX32.

DHX32 is also known for its role in the regulation of microRNA (miRNA) expression. miRNA are small non-coding RNAs that play a critical role in post-transcriptional gene regulation by binding to specific target genes and regulating their translation into protein. DHX32 has been shown to interact with miRNA-21, a miRNA that is involved in the regulation of cell proliferation and survival.

DHX32 is also involved in the regulation of gene expression in the context of RNA polymerase II (RNA-II). RNA-II is a complex protein that is responsible for the transcription of DNA into RNA. DHX32 has been shown to interact with the protein p16, which is a component of RNA-II.

DHX32 is a potent inhibitor of RNA polymerase II-mediated gene expression. It has been shown to inhibit the activity of RNA-II in the presence of an agonist and to increase the rate of degradation of RNA-II in cells treated with an agonist.

DHX32 is also a potential biomarker for pre-mRNA splicing disorders. Pre-mRNA splicing disorders are a group of genetic disorders that are characterized by the abnormal regulation of pre-mRNA splicing. These disorders can be caused by mutations in genes involved in the pre-mRNA splicing process, including DHX32.

DHX32 has been shown to be a missense mutant in a patient with pre-mRNA splicing disorder. The patient had a defect in the regulation of pre-mRNA splicing and was affected by a range of symptoms, including developmental delays, hearing loss, and learning difficulties. The analysis of the patient's DNA revealed a mutation in the DHX32 gene.

Conclusion

In conclusion, DHX32 is a protein that is involved in the regulation of pre-mRNA splicing in eukaryotic cells. It functions as a pre-mRNA splicing factor and is also involved in the regulation of miRNA and RNA polymerase II-mediated gene expression. DHX32 is a potential drug target and biomarker for pre-mRNA splicing disorders. Further research is needed to fully understand the role of DHX32 in

Protein Name: DEAH-box Helicase 32 (putative)

More Common Targets